CHNA

Loncar China BioPharma ETF

Delisted

CHNA was delisted on the 20th of October, 2023.

4 hedge funds and large institutions have $631K invested in Loncar China BioPharma ETF in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
FEM
1
Fulcrum Equity Management
Texas
$464K +$464K +9,755 New
Morgan Stanley
2
Morgan Stanley
New York
$104K
Osaic Holdings
3
Osaic Holdings
Arizona
$44K +$44K +922 New
MCM
4
MV Capital Management
Maryland
$19K +$19K +400 New
Jane Street
5
Jane Street
New York
-$773K -20,956 Closed
UBS Group
6
UBS Group
Switzerland
-$62K -1,681 Closed
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
-$4K -100 Closed